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Abstract
© 2015.  Published  by  The  Company  of  Biologists  Ltd.  Lipid-containing  alveolar  interstitial
fibroblasts  (lipofibroblasts)  are  increasingly  recognized  as  an  important  component  of  the
epithelial stem cell  niche in the rodent lung. Although lipofibroblasts were initially believed
merely to assist type 2 alveolar epithelial cells in surfactant production during neonatal life,
recent evidence suggests that these cells are indispensable for survival and growth of epithelial
stem cells during adulthood. Despite increasing interest in lipofibroblast biology, little is known
about  their  cellular  origin  or  the  molecular  pathways  controlling  their  formation  during
embryonic development. Here, we showthat a population of lipid-droplet-containing stromal
cells emerges in the developing mouse lung between E15.5 and E16.5. This is accompanied by
significant upregulation, in the lung mesenchyme, of peroxisome proliferator-activated receptor
gamma (master switch of lipogenesis), adipose differentiation-related protein (marker of mature
lipofibroblasts) and fibroblast growth factor 10 (previously shown to identify a subpopulation of
lipofibroblast progenitors). We also demonstrate that although only a subpopulation of total
embryonic lipofibroblasts derives from Fgf10+ progenitor cells, in vivo knockdown of Fgfr2b
ligand activityand reduction in Fgf10 expression lead to global reduction in the expression levels
of lipofibroblast markers at E18.5. Constitutive Fgfr1b knockouts and mutants with conditional
partial inactivation of Fgfr2b in the lung mesenchyme reveal the involvement of both receptors
in lipofibroblast formation and suggest a possible compensation between the two receptors. We
also provide data from human fetal lungs to demonstrate the relevance of our discoveries to
humans.  Our  results  reveal  an  essential  role  for  Fgf10  signaling  in  the  formation  of
lipofibroblasts during late lung development.
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